Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Carmela Nappi , Valeria Gaudieri , Alberto Cuocolo Added: 3 years ago
Evaluating stress-induced myocardial perfusion defects by non-invasive myocardial perfusion imaging (MPI) modalities has taken a leading role in the identification of flow-limiting epicardial coronary artery disease (CAD); it has excellent diagnostic and prognostic value. Non-invasive MPI can be performed using conventional and novel gamma cameras or PET/CT.1 A range of imaging techniques has… View more
Author(s): Elved B Roberts , Nicholas D Palmer Added: 3 years ago
Late stent thrombosis has been a concern for interventional cardiologists since the early days of drug-eluting stent (DES) technology. Although the problem did not appear common, a series of angiographically documented late stent thromboses from the Thoraxcenter Rotterdam was published in 2004, sounding a cautionary, albeit non-alarmist, note.1 In 2005, a prospective observational cohort study of… View more
Author(s): Sebastian Kelle , Eike Nagel Added: 3 years ago
Magnetic resonance imaging (MRI) is a powerful imaging modality for diagnostic cardiology and research. This imaging method provides combined diagnostic information of different tissue characteristics, such as the visualisation of the vascular tree and cardiac anatomy and function, as well as measurements of blood flow in the vessels, ventricular wall motion, myocardial perfusion and viability… View more
Author(s): Lazar Mandinov , Federico M Asch , Eberhard Grube Added: 3 years ago
Functional mitral regurgitation (FMR) in patients with chronic myocardial ischaemia/infarction or dilated cardiomyopathy results from significant left ventricular remodelling with papillary muscle displacement and restrictive leaflet motion.1,2 Almost invariably, the mitral annulus is dilated and deformed, whereas the valve leaflets are morphologically normal. Surgically, annular reduction can be… View more
Author(s): David E Allie , Chris J Herbert , Craig M Walker Added: 3 years ago
Despite the recent introduction of vascular closure device (VCD) technology, vascular access site complications remain the leading source of morbidity and costs after the approximately eight to eight-and-a-half million percutaneous catheter-based procedures performed annually worldwide.1 VCD trials consistently demonstrate increased patient satisfaction, early ambulation, and decreased hospital… View more